- Home
- WBX vs ALEC Comparison
WBX vs ALEC Comparison
Compare WBX & ALEC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | WBX | ALEC |
|---|---|---|
| Founded | 2015 | 2013 |
| Country | Spain | United States |
| Employees | N/A | N/A |
| Industry | Industrial Specialties | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 118.0M | 133.2M |
| IPO Year | N/A | 2019 |
Fundamental Metrics
Financial Performance| Metric | WBX | ALEC |
|---|---|---|
| Price | $3.02 | $1.47 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 4 | 8 |
| Target Price | ★ $9.00 | $3.50 |
| AVG Volume (30 Days) | 26.7K | ★ 1.7M |
| Earning Date | 11-05-2025 | 11-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $174,593,453.00 | $69,048,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $33.37 | $160.66 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 12.26 |
| 52 Week Low | $2.85 | $0.87 |
| 52 Week High | $14.40 | $3.40 |
Technical Indicators
Market Signals| Indicator | WBX | ALEC |
|---|---|---|
| Relative Strength Index (RSI) | 32.36 | 52.61 |
| Support Level | $2.90 | $1.18 |
| Resistance Level | $3.21 | $1.39 |
| Average True Range (ATR) | 0.25 | 0.10 |
| MACD | 0.03 | 0.07 |
| Stochastic Oscillator | 12.15 | 83.33 |
Price Performance
Historical ComparisonAbout WBX Wallbox N.V.
Wallbox NV is a smart electric vehicle charging and energy management company. It creates a smart charging system combining technology design that manages the communication between the user, vehicle, grid, building, and charger. The company designs, manufactures, and distributes faster, simpler EV charging solutions for residential, business, and public use. Its smart charging product portfolio includes Level 2 alternating current chargers for home and business applications and direct current fast chargers for public applications. The company has three reportable operating segments; Europe, Middle East and Asia (EMEA), its key revenue-generating segment, North America, and Asia-Pacific.
About ALEC Alector Inc.
Alector Inc is a clinical-stage biopharmaceutical company. It is engaged in developing a novel therapeutic approach for the treatment of neurodegeneration. The firm is involved in developing therapies that are designed to simultaneously counteract pathologies by restoring healthy immune function to the brain. Its pipeline products include AL001, AL002, AL003, and AL101.